About this trial
This household-based prospective cohort study aims to stablish the household transmission of Respiratory syncytial virus and S. pneumoniae especially in the elderly and infants/children as well as inter-relationship between S. pneumoniae and Respiratory syncytial virus.
Eligibility criteria
Qualifiers
Indicator case: Babies under 5 months of age were born in Mackay Children's Hospital and had no acute respiratory infection-like symptoms that required medical intervention when they agreed to participate in the trial.
Family members: family members living with the Indicator case, including 2-5 years old siblings, parents and grandparents over 65 years old.
Willing to sign the informed consent form and agree to join the official LINE account to receive research tracking.
Disqualifiers
Babies older than 5 months
Co-morbid medical conditions of the baby such as chronic lung disease, cyanotic congenital heart disease, neuromuscular disease and a primary immunodeficiency.
Family members who do not live with the Indicator case
Family with grandparents younger than 65 years old
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Locations
Sponsors and collaborators
Mackay Memorial Hospital
Lead sponsor
Merck Sharp & Dohme LLC
Collaborator